Article citationsMore>>

Takahashi, Y., Mai, M., Sawabu, N. and Nishioka, K. (2005) A Pilot Study of Individualized Maximum Repeatable Dose (iMRD), a New Dose Finding System, of Weekly Gemcitabine for Patients with Metastatic Pancreas Cancer. Pancreas, 30, 206-210.
https://doi.org/10.1097/01.mpa.0000153335.73352.c7

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top